FR2427331A2 - Derives de l'hydantoine et medicaments contenant ces substances - Google Patents

Derives de l'hydantoine et medicaments contenant ces substances

Info

Publication number
FR2427331A2
FR2427331A2 FR7913823A FR7913823A FR2427331A2 FR 2427331 A2 FR2427331 A2 FR 2427331A2 FR 7913823 A FR7913823 A FR 7913823A FR 7913823 A FR7913823 A FR 7913823A FR 2427331 A2 FR2427331 A2 FR 2427331A2
Authority
FR
France
Prior art keywords
substances
products containing
medicinal products
hydantoin derivatives
hydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913823A
Other languages
English (en)
French (fr)
Other versions
FR2427331B2 (de
Inventor
Albert Gordon Caldwell
Norman Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2427331A2 publication Critical patent/FR2427331A2/fr
Application granted granted Critical
Publication of FR2427331B2 publication Critical patent/FR2427331B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7913823A 1978-05-31 1979-05-30 Derives de l'hydantoine et medicaments contenant ces substances Granted FR2427331A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25575/78A GB1599740A (en) 1978-05-31 1978-05-31 Hydantoin derivatives

Publications (2)

Publication Number Publication Date
FR2427331A2 true FR2427331A2 (fr) 1979-12-28
FR2427331B2 FR2427331B2 (de) 1983-01-28

Family

ID=10229898

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913823A Granted FR2427331A2 (fr) 1978-05-31 1979-05-30 Derives de l'hydantoine et medicaments contenant ces substances

Country Status (11)

Country Link
JP (1) JPS554371A (de)
AU (1) AU4762579A (de)
BE (1) BE876670R (de)
DE (1) DE2922070A1 (de)
FR (1) FR2427331A2 (de)
GB (1) GB1599740A (de)
IL (1) IL57436A0 (de)
IT (1) IT1164693B (de)
NL (1) NL7904311A (de)
SE (1) SE7904700L (de)
ZA (1) ZA787354B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014076A2 (de) * 1979-01-18 1980-08-06 Beecham Group Plc Hydantoinderivate, ihre Herstellung und pharmazeutische Zusammensetzungen
CN1084792C (zh) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 高风温高炉热风炉空气、煤气预热方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019223A1 (de) * 1979-05-09 1980-11-26 The Wellcome Foundation Limited Optisch aktive Hydantoinderivate, ihre Herstellung, sie enthaltende pharmazeutische Formulierungen und Zwischenprodukte
EP0023083A1 (de) * 1979-06-27 1981-01-28 Beecham Group Plc Oxodiazol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung
US4908456A (en) * 1989-04-05 1990-03-13 Takatori Corporation Process for preparing methylolated hydantoins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (fr) * 1976-06-03 1978-03-24 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
EP0001238A1 (de) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Hydantoinderivate, deren Herstellung, sowie diese Verbindungen enthaltende Arzneimittel, und deren Zwischenprodukte

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (fr) * 1976-06-03 1978-03-24 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
EP0001238A1 (de) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Hydantoinderivate, deren Herstellung, sowie diese Verbindungen enthaltende Arzneimittel, und deren Zwischenprodukte

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014076A2 (de) * 1979-01-18 1980-08-06 Beecham Group Plc Hydantoinderivate, ihre Herstellung und pharmazeutische Zusammensetzungen
EP0014076A3 (en) * 1979-01-18 1980-09-17 Beecham Group Limited Hydantoin derivatives, their preparation and pharmaceutical compositions
CN1084792C (zh) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 高风温高炉热风炉空气、煤气预热方法

Also Published As

Publication number Publication date
FR2427331B2 (de) 1983-01-28
AU4762579A (en) 1979-11-22
DE2922070A1 (de) 1979-12-06
BE876670R (fr) 1979-11-30
GB1599740A (en) 1981-10-07
SE7904700L (sv) 1979-12-01
IT7949253A0 (it) 1979-05-30
IT1164693B (it) 1987-04-15
ZA787354B (en) 1980-08-27
IL57436A0 (en) 1979-09-30
NL7904311A (nl) 1979-12-04
JPS554371A (en) 1980-01-12

Similar Documents

Publication Publication Date Title
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2416234A1 (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2400512A1 (fr) Nouveaux nitro-imidazoles, leur preparation et leur application en tant que medicaments
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2433512A1 (fr) Derives de l'indane et medicaments qui en contiennent
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR2360601A1 (fr) Nouveaux derives d'acides phosphoneux, leur preparation et leur application en tant que medicaments
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
FR2370744A1 (fr) Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
FR2377419A1 (fr) Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2415103A1 (fr) Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2427331A2 (fr) Derives de l'hydantoine et medicaments contenant ces substances
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
FR2355830A1 (fr) Nouveaux derives de 6-7-benzomorphane, leur obtention et composition pharmaceutique les contenant
OA04707A (fr) Nouveaux dérivés de l'urée et de l'hydantoïne et compositions régulatrices pour la croissance de plantes.
FR2356643A1 (fr) 5-0-acyl-imidazole-4-carboxamides, leur obtention et composition pharmaceutique en contenant
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
FR2355012A1 (fr) Nouveaux derives de dihydro- et tetrahydro-iminothiazine, et leur application en tant que medicaments
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant